EUnetHTA Plenary Assembly Strategic developments Flora Giorgio DG Health and Consumer
EU Objectives in HTA Article 15 Directive 2011/24: • Support cooperation between national HTA Authorities • Support MS in the provision of objective, reliable, timely, transparent , comparable and transferable information […] to enable effective exchange of information • Avoid duplication of assessments
EU Cooperation in HTA – where we are • HTA Network (art 15 Directive 2011/24) – strategic level (2 meetings 10/2013 4/2014) MS representatives (mainly MoH); EMA associated • EUnetHTA (Joint Action HP) – scientific level – on-going until October 2015 HTA doers (mainly HTA Agencies) • Two levels in synergy and complementary • Involvement of stakeholders - both @ strategic level and scientific level
EU cooperation in HTA – VISION • New phase of cooperation from "agreeing on " to "doing and learning together" PILOTS • Up take of joint work in national activities MAINSTREAM • "Life cycle" approach to health technologies More synergies with regulators and payers DEFRAGMENTATION • From "projects" to "permanent" cooperation SUSTAINABILITY HTA Network DRAFT Strategy Paper
EU cooperation in HTA – HOW? • A sustainable Network of HTA Agencies working and learning together to get the evidence needed for national HTA Reports JOINT WORK • Different level of commitments to do and re-use Joint Work
EU cooperation in HTA – HOW? II • Joint Work • Early Dialogues • REA • Full HTA • Methodology development • IT Tools • …
EU cooperation in HTA – HOW? II • Assess • Prioritise • Make it happen
EU cooperation in HTA – Future ? • From Project based to permanent structure • JA 3 up to 2020 Max • post 2020 ? Joint work – HTA Agencies Coordination work – central Secretariat
Reflection • What’s best done together? • What helps you in your national activities ? • What are you prepared to invest in ?
Thank you Flora.giorgio@ec.europa.eu http://ec.europa.eu/health/technolog y_assessment/policy/index_en.htm
Secretariat for scientific cooperation in EMA? • A “different” EMA • A decentralized model (not CHMP) • Scientific synergies with regulators fro Pharma • New concept to be designed for MD and other technologies
Conclusions II • Are YOU ready to play your part? • National HTA agencies • Competent authorities/ payers • Technology developers • All stakeholders (patients, professionals, academic bodies, private experts …) • … • "New" cooperation on HTA in Europe can be reality only if all subscribe and engage in shaping it !
History about EC activity on HTA • Health Programme – Projects • EUR-ASSES 1994-1997 • ECHTA/ECHAI 1999- 2001 • EUnetHTA 2006-2008 • FP 7 – Projects • 2012 on going • Health Programme – Joint Actions • EUnetHTA 1 – 2010-2012 • EUnetHTA 2 – 2012-2015 Total EU Budget over 30 million €
Recommend
More recommend